What's the news on the popular stocks in the market today?

Here is some news about popular stocks in the market today:

1. **Nvidia and AMD's Agreement with the U.S. Government**: Nvidia and AMD have agreed to give the U.S. government a share of revenues from chip sales in China. This agreement, which involves Nvidia sharing 15% of revenues from sales of its H20 AI chip and AMD paying the same percentage of MI308 chip revenues, is part of a deal to secure export licenses for their products. This unusual arrangement could have implications for the semiconductor industry and the trade relationship between the U.S. and China.
2. **S4 Capital's Potential Acquisition of MSQ Partners**: S4 Capital has confirmed preliminary discussions with MSQ Partners regarding a potential acquisition. This proposal involves MSQ Partners being acquired by S4 Capital. The confirmation was in response to press speculation and no further details about the potential terms or timeline have been disclosed.
3. **Plus500's Shareholder Payout**: Plus500 has announced it will return $165 million to shareholders through buybacks and dividends after posting positive first-half results. This includes $90 million in share repurchases and $75 million in dividends, which is a significant amount compared to the company's market capitalization.
4. **Orchestra BioMed's FDA-Approved Protocol Update**: Orchestra BioMed has announced the rollout of an FDA-approved protocol update for the BACKBEAT global pivotal study. This update significantly expands patient eligibility criteria, potentially increasing the pool of eligible patients available for enrollment. This development is significant for the company's clinical trials and could have implications for patients with hypertensive conditions.
5. **Heron Therapeutics' Comprehensive Capital Restructuring**: Heron Therapeutics has completed a comprehensive capital restructuring designed to enhance financial flexibility and reduce total debt. This restructuring includes the issuance of new senior convertible notes and a private placement with select investors, which could strengthen the company's balance sheet and support its commercial execution and pipeline priorities.
6. **SGBX Safe & Green Holdings Corp.'s Recent Developments**: Safe & Green Holdings Corp. has been active in acquisitions and contract signings. They have acquired certain assets of Sherman Oil Company and have signed a contract with Three Pines Leasing. Additionally, they have announced a new construction contract and have entered into a non-binding letter of intent to acquire key assets and business operations of County Line Industrial, LLC. These developments highlight the company's growth and expansion efforts in the modular structures sector.
7. **SOUN SoundHound AI's Product Launches and Partnerships**: SoundHound AI has launched Vision AI, an advanced visual understanding system integrated with its voice-first platform. This launch is expected to enhance the company's conversational AI capabilities. Additionally, SoundHound AI has reported record second-quarter results, raising the full-year outlook, and has partnered with Acrelec to revolutionize drive-thru operations. These developments highlight the company's growth and innovation in the AI sector.
8. **MRM MEDIROM Healthcare Technologies Inc.'s Market Activity**: MEDIROM Healthcare Technologies Inc. has seen a significant increase in its stock price, which some media attribute to a potential investment or strategic move. The company has also regained compliance with NASDAQ's continued listing requirements, indicating stability in its financial performance.
9. **NCNA NuCana plc's Stock Performance and Corporate Actions**: NuCana plc has seen a decrease in its stock price and has been involved in several corporate actions, including the cancellation of all outstanding Series A warrants and the implementation of an ADS ratio change. These actions are part of the company's strategic restructuring aimed at enhancing financial flexibility.
10. **IXHL Incannex Healthcare Inc.'s Clinical Developments**: Incannex Healthcare Inc. has reported positive patient-reported outcomes and compelling Phase 2 efficacy data for IHL-42X in obstructive sleep apnoea. The company has also confirmed a strong cash position and has no plans to